Furthermore, administration of bovine IAP prevents pathophysiological changes in mouse models of chronic colitis [21] by inhibiting pro-inflammatory pathways mediated by LPS, a gram negative bacterial endotoxin [20], and UDP [3] and preventing the development of metabolic syndrome in IAP knockout mice [22]. The gene discussed is ALPI; the disease is metabolic syndrome.